Your browser doesn't support javascript.
loading
Efficacy and safety of boosted darunavir-based antiretroviral therapy in HIV-1-positive patients: results from a meta-analysis of clinical trials.
Antinori, A; Lazzarin, A; Uglietti, A; Palma, M; Mancusi, D; Termini, R.
Afiliação
  • Antinori A; HIV/AIDS Department, National Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS, Roma, Italy.
  • Lazzarin A; Department of Infectious Diseases, San Raffaele Scientific Institute, Milan, Italy.
  • Uglietti A; Janssen-Cilag SpA, Medical Affairs Department, Infectious Diseases, Cologno Monzese, (MI), Italy.
  • Palma M; Janssen-Cilag SpA, Medical Affairs Department, Infectious Diseases, Cologno Monzese, (MI), Italy.
  • Mancusi D; Janssen-Cilag SpA, Medical Affairs Department, Infectious Diseases, Cologno Monzese, (MI), Italy. dmancusi@its.jnj.com.
  • Termini R; Janssen-Cilag SpA, Medical Affairs Department, Infectious Diseases, Cologno Monzese, (MI), Italy.
Sci Rep ; 8(1): 5288, 2018 03 27.
Article em En | MEDLINE | ID: mdl-29588457
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article